ライフサイエンスコーパス: cigarette smoking

1 on employed (pharmacologic administration or cigarette smoking).

2 cardiac diseases or cardiac risks, including cigarette smoking.

3 nderstanding the brain mechanisms underlying cigarette smoking.

4 used e-cigarettes (18.9%) progressed toward cigarette smoking.

5 sk for subsequent progression to traditional cigarette smoking.

6 All analyses included fine adjustment for cigarette smoking.

7 their appeal to youth and curb the onset of cigarette smoking.

8 The main exposure was cigarette smoking.

9 s associated with progression to traditional cigarette smoking.

10 of nicotine, the main addictive substance in cigarette smoking.

11 eir potential to undermine efforts to reduce cigarette smoking.

12 he initiation and progression of combustible cigarette smoking.

13 r controlling for age, sex, alcohol use, and cigarette smoking.

14 characterized a novel microRNA signature of cigarette smoking.

15 was largely concentrated in snus use but not cigarette smoking.

16 limit the future population-level burden of cigarette smoking.

17 de changes in gene expression in response to cigarette smoking.

18 eversible airflow obstruction usually due to cigarette smoking.

19 nant cause of lung cancer in women is active cigarette smoking.

20 configuration and with greater frequency of cigarette smoking.

21 rsons, it did not appear to be influenced by cigarette smoking.

22 ntrols matched for age, sex, handedness, and cigarette smoking.

23 lete methylation capacity with older age and cigarette smoking.

24 Most trials examined only cigarette smoking.

25 gar and pipe smoking were stratified by ever cigarette smoking.

26 mutagen, specifically ionizing radiation or cigarette smoking.

27 d initial use of e-cigarettes and subsequent cigarette smoking.

28 cigarette smoking initiation and past 30-day cigarette smoking.

29 on pulmonary function decline as mediated by cigarette smoking.

30 whether e-cigarette use affects the risk of cigarette smoking.

31 OPSCC and a history of </= 10 pack-years of cigarette smoking.

32 otentially offer a lower risk alternative to cigarette smoking.

33 previous genome-wide association studies of cigarette smoking.

34 mprecise estimates, with limited control for cigarette smoking.

35 ciated with increased exercise and decreased cigarette smoking.

36 mmon mental disorders (1.77, 1.08-2.90), and cigarette smoking (2.01, 1.29-3.14).

37 e following RFs were considered: (1) current cigarette smoking, (2) dyslipidemia, (3) diabetes mellit

38 conditions: (1) nicotine patch+denicotinized cigarette smoking, (2) nicotine patch+abstinence from sm

39 She discontinued cigarette smoking 20 years ago and has an occasional gla

40 Further, employees had a lower prevalence of cigarette smoking (9.7 vs. 17.3% in 2010, P < 0.001) com

41 emale sex (around 2-fold increased odds) and cigarette smoking (about 5-fold reduced odds) predicted

42 ent cigarette smoking initiation and current cigarette smoking, accounting for established sociodemog

43 Cigarette smoking adds an estimated $100 billion in annu

44 hese data suggest that, after accounting for cigarette smoking, adherence to a set of healthy behavio

45 Our risk model included current cigarette smoking (adjusted odds ratio (OR) = 3.3, 95% c

46 3; 95% CI, 1.43-9.76, respectively), current cigarette smoking (adjusted odds ratios: 2.48; 95% CI, 1

47 0.56, respectively), and higher intensity of cigarette smoking (adjusted proportional odds ratios: 2.

48 o be associated with young age at diagnosis, cigarette smoking, advanced stage at presentation, and a

49 rst aim of this study was to clarify whether cigarette smoking affects tear secretion, goblet cell de

50 of this study provide further evidences that cigarette smoking affects the regenerative potentials of

51 Parity, oral contraceptive use, cigarette smoking, age at menarche, and diabetes were as

52 ratio [aHR], 2.4; 95% CI, 1.5-3.9), current cigarette smoking (aHR, 1.9; 95% CI, 1.1-3.4), and syste

53 nce use has declined over the last 30 years, cigarette smoking, alcohol and illicit drug use, sexual

54 ed non-significant when adjusted for current cigarette smoking, alcohol consumption, and illicit drug

55 ndex, education, family history of diabetes, cigarette smoking, alcohol drinking, physical activity,

56 Besides accelerating adult FEV1 decline, cigarette smoking also modifies how early-life exposures

57 These observations provide evidence that cigarette smoking alters the DNA methylation patterning

58 ng tendency, parental cigarette smoking, and cigarette smoking among friends.

59 -environment interactions were observed with cigarette smoking and a SNP in ADIPOR1 in African Americ

60 the association between biomarker-confirmed cigarette smoking and acute respiratory distress syndrom

61 n which information on important confounders-cigarette smoking and alcohol consumption-was lacking.

62 , being unmarried, living in the rural area, cigarette smoking and alcohol drinking were associated w

63 have been formally established as caused by cigarette smoking and are included in official estimates

64 may be a part of the biological link between cigarette smoking and atherosclerosis.

65 Cigarette smoking and attention-deficit/hyperactivity di

66 essed the relationship between self-reported cigarette smoking and biomarker levels, the validity of

67 l airway collapse [ECAC]) is associated with cigarette smoking and chronic obstructive pulmonary dise

68 ideal treatment medication would reduce both cigarette smoking and cocaine abuse.

69 An ideal pharmacotherapy would reduce both cigarette smoking and cocaine abuse.

70 gnificantly modifies the association between cigarette smoking and COPD.

71 of snus independently predicted the onset of cigarette smoking and current cigarette smoking at follo

72 ehensively determine the association between cigarette smoking and DNA methylation, we conducted a me

73 We examined the association between cigarette smoking and drinking outcomes in the COMBINE (

74 Frequency of combustible cigarette smoking and e-cigarette use within the past 30

75 been achieved in reducing the prevalence of cigarette smoking and exposure to secondhand smoke.

76 ding assessment of possible joint effects of cigarette smoking and fine particulate matter (particula

77 e pulmonary disease (COPD) is linked to both cigarette smoking and genetic determinants.

78 The negative health effects of cigarette smoking and HIV infection are synergistic.

79 We investigated associations between cigarette smoking and incidence of basal cell carcinoma

80 The association between cigarette smoking and inflammation is well known.

81 f DNA methylation in the association between cigarette smoking and inflammation.

82 ation in monocytes, a cell type sensitive to cigarette smoking and involved in atherogenesis, may be

83 Evidence of an association between cigarette smoking and latent tuberculosis infection (LTB

84 ty of exposure to 15 case-control studies of cigarette smoking and lung cancer (1985-2009).

85 fication of the association of pack-years of cigarette smoking and lung cancer by intensity of cigare

86 Application of our method in this example of cigarette smoking and lung cancer demonstrated that redu

87 study criteria, including no current tobacco cigarette smoking and no known health problems or prescr

88 s these offer enticing clues that, even amid cigarette smoking and other commonalities in the etiolog

89 DR was associated with diabetes duration, cigarette smoking and peripheral neuropathy.

90 y have implications for predicting long-term cigarette smoking and problems with other substance abus

91 Except for the association between cigarette smoking and provoked VTE, which is potentially

92 outcome measures were weighted prevalence of cigarette smoking and quit ratio (ratio of former smoker

93 e sought to describe a microRNA signature of cigarette smoking and relate it to smoking-associated cl

94 irway inflammation and oxidative stress from cigarette smoking and related carcinogens.

95 y was to investigate the association between cigarette smoking and smoking cessation and the prevalen

96 s are crucial for reducing the prevalence of cigarette smoking and smoking-related illnesses.

97 essment of interactions with patients' heavy cigarette smoking and the relationship of this mechanism

98 tion persists beyond adolescence by studying cigarette smoking and the use of snus (Swedish oral mois

99 Cigarette smoking and tooth loss are seldom considered c

100 n the frequency and intensity of combustible cigarette smoking and vaping.

101 Educational level, cigarettes smoking and physical exercise were not signif

102 rom smoking, (3) placebo patch+denicotinized cigarette smoking, and (4) placebo patch+abstinence from

103 entry, adjusting for age, education, income, cigarette smoking, and alcohol consumption.

104 level, sensation-seeking tendency, parental cigarette smoking, and cigarette smoking among friends.

105 fficients for age, sex, waist circumference, cigarette smoking, and family history of colorectal canc

106 s: older age, white race, diabetes mellitus, cigarette smoking, and hypertension.

107 teristics with regard to HLA shared epitope, cigarette smoking, and inflammation (cytokines).

108 hernia, advanced age, male sex, white race, cigarette smoking, and obesity with an intra-abdominal b

109 reviously treated TB, co-infection with HIV, cigarette smoking, and overcrowding were risk factors as

110 ears with at least a 30 pack-year history of cigarette smoking, and, if a former smoker, had quit wit

111 olesterol, WBC count, and history of current cigarette smoking; and change in CRVE is independently a

112 Nevertheless, there is limited research on cigarette smoking as a potential predictor of differenti

113 with ever use of e-cigarettes or past 30-day cigarette smoking associated with past 30-day e-cigarett

114 s, and the pooled odds ratio for past 30-day cigarette smoking at follow-up was 4.28 (95% CI, 2.52-7.

115 The pooled probabilities of past 30-day cigarette smoking at follow-up were 21.5% for baseline p

116 e smoking initiation, current (past 30 days) cigarette smoking at follow-up, and the intensity of cig

117 snus use were associated with high-intensity cigarette smoking at follow-up.

118 e smoking at follow-up, and the intensity of cigarette smoking at follow-up.

119 d the onset of cigarette smoking and current cigarette smoking at follow-up.

120 e past 30-day e-cigarette users, past 30-day cigarette smoking at follow-up.

121 Our data indicate that cigarette smoking before first cancer diagnosis increase

122 cutive functions, plays an important role in cigarette smoking behavior.

123 versive conditioning during sleep will alter cigarette-smoking behavior during ensuing wakefulness.

124 ditioning during sleep significantly reduced cigarette-smoking behavior in a sleep stage-dependent ma

125 We also included data from India on cigarette smoking, bidi smoking, chewing tobacco, and se

126 use of nonsteroidal anti-inflammatory drugs, cigarette smoking, body mass index, and history of polyp

127 ncentrations correlated with age, sex, race, cigarette smoking, body mass index, inheritance of the e

128 practice.A 64-year-old man with a history of cigarette smoking but no significant comorbidities prese

129 as associated with a decreased prevalence of cigarette smoking, but not with lower prevalence of obes

130 on of the excess odds ratio per pack-year of cigarette smoking by time since smoking cessation among

131 ihypertensive medication, diabetes mellitus, cigarette smoking, cardiovascular disease history, atria

132 Cigarette smoking causes emphysema, a fatal disease invo

133 the association between e-cigarette use and cigarette smoking cessation among adult cigarette smoker

134 The effect of duration of cigarette smoking cessation on colorectal cancer risk by

135 The primary endpoint was cigarette smoking cessation.

136 Members had a lower prevalence of cigarette smoking compared to nonmembers (overall year-a

137 A) have a substantially higher prevalence of cigarette smoking compared to the general population.

138 d with changes in CBF from the denicotinized cigarette smoking conditions to the abstinent conditions

139 The risk of death from cigarette smoking continues to increase among women and

140 Cigarette smoking contributes to the development of dest

141 ciation between baseline e-cigarette use and cigarette smoking, controlling for sex, age, race/ethnic

142 c obstructive pulmonary disease (COPD) where cigarette smoking (CS) is a risk factor for disease deve

143 Cigarette smoking damages the extracellular matrix in a

144 Progression to cigarette smoking, defined using 3 specific states along

145 , use of antihypertensive treatment, current cigarette smoking, diabetes status, body mass index, C-r

146 sociation between 5 modifiable risk factors (cigarette smoking, diabetes, elevated low-density lipopr

147 ere older than 50 years of age, a history of cigarette smoking did not appear to influence the associ

148 Tobacco cigarette smoking did not significantly influence relaps

149 that the timing of dopaminergic responses to cigarette smoking differs between men and women.

150 Taken together, our results suggest that cigarette smoking disrupts endogenous proresolving pathw

151 Cigarette smoking during pregnancy is a major public hea

152 Maternal cigarette smoking during pregnancy remains one of the mo

153 Age, male sex, alcohol drinking, cigarette smoking, elevated alanine aminotransferase, se

154 cy at age 40 years associated with change in cigarette smoking exposure constituted another measure o

155 in substance use (drug use, alcohol use, and cigarette smoking) following surgery to compensate for a

156 Smokers were abstinent from cigarette smoking for 12 hours for all sessions.

157 Cigarette smoking has a broad impact on genome-wide meth

158 Cigarette smoking has been associated with higher risk o

159 pulmonary disease (COPD) and persists after cigarette smoking has stopped.

160 e (a composite of drug use, alcohol use, and cigarette smoking, hereafter referred to as composite su

161 hree to six) were obtained for cannabis use, cigarette smoking, high-risk alcohol use, depression and

162 sociated with higher odds of ever or current cigarette smoking, higher odds of established smoking, h

163 National Health Interview Surveys yielded cigarette smoking histories for the US adult population

164 atus (surrogate of human papillomavirus) and cigarette smoking history (pack-years) randomly assigned

165 disease, two diagnostic breathing tests, and cigarette smoking history.

166 haviors, particularly through differences in cigarette smoking; however, the association with fatal C

167 on of modifiable risk factors: dyslipidemia, cigarette smoking, hypertension, obesity, and hyperglyce

168 treatment, including precipitous declines in cigarette smoking, improvements in hypertension treatmen

169 Cigarette smoking in asthma is associated with a cortico

170 ion into lung lining fluid was diminished by cigarette smoking in humans and mice.

171 roduced nicotine pharmacokinetics resembling cigarette smoking in humans.

172 A history of cigarette smoking in patients with new-onset adult asthm

173 is associated with the highest prevalence of cigarette smoking in the United States, and is also a ti

174 The disease risks from cigarette smoking increased in the United States over mo

175 tes mellitus, and radiation therapy (but not cigarette smoking) increased the risk for anastomotic le

176 Cigarette smoking increases complication risk in surgica

177 These combined negative effects suggest that cigarette smoking increases interleukin-18 levels throug

178 Cigarette smoking increases overall mortality, but it is

179 Cigarette smoking increases risk for multiple diseases.

180 Cigarette smoking increases the risk of developing IPF s

181 Cigarette smoking-induced changes in alveolar macrophage

182 We hypothesized that cigarette smoking induces extensive transcriptomic chang

183 snus use were independently associated with cigarette smoking initiation (adjusted odds ratios: 2.56

184 ine snus use were associated with subsequent cigarette smoking initiation and current cigarette smoki

185 associated with greater risk for subsequent cigarette smoking initiation and past 30-day cigarette s

186 ngitudinal studies reporting odds ratios for cigarette smoking initiation associated with ever use of

187 Among baseline never cigarette smokers, cigarette smoking initiation between baseline and follow

188 moking, the pooled odds ratio for subsequent cigarette smoking initiation was 3.62 (95% CI, 2.42-5.41

189 The pooled probabilities of cigarette smoking initiation were 30.4% for baseline eve

190 Among baseline non-cigarette smokers, cigarette smoking initiation, current (past 30 days) cig

191 Cigarette smoking is a chronic relapsing brain disorder,

192 These data indicate that current cigarette smoking is a clinically important marker for i

193 Cigarette smoking is a leading cause of preventable mort

194 Cigarette smoking is a leading modifiable cause of death

195 Cigarette smoking is a major factor for the development

196 Cigarette smoking is a major public health danger.

197 Cigarette smoking is a major risk factor for acquisition

198 Cigarette smoking is a major risk factor for chronic obs

199 Cigarette smoking is a major risk factor in the developm

200 Cigarette smoking is a risk factor for many perioperativ

201 Cigarette smoking is a risk factor for type 2 diabetes.

202 Cigarette smoking is a significant risk factor for Alzhe

203 While cigarette smoking is a strong risk factor for invasive p

204 Prenatal exposure to maternal cigarette smoking is a well-established risk factor for

205 Maternal cigarette smoking is a well-established risk factor for

206 Cigarette smoking is an established environmental risk f

207 Cigarette smoking is associated with a decreased inciden

208 Cigarette smoking is associated with cognitive decline a

209 his study adds to the existing evidence that cigarette smoking is associated with higher all-cause an

210 Purpose Cigarette smoking is associated with increased incidence

211 Cigarette smoking is associated with metabolite abnormal

212 Current cigarette smoking is associated with reduced acute respo

213 Cigarette smoking is associated with structural changes

214 Cigarette smoking is linked to important aspects of tube

215 Intriguingly, cigarette smoking is most strongly and robustly associat

216 rs; and prohibiting ENDS use in places where cigarette smoking is prohibited.

217 Cigarette smoking is significantly associated with new-o

218 Despite well-established evidence that cigarette smoking is the largest modifiable risk factor

219 Cigarette smoking is the leading cause of preventable de

220 Cigarette smoking is the leading preventable cause of de

221 Cigarette smoking is the main risk factor for COPD, and

222 he association between psychotic illness and cigarette smoking is well known, the reasons are unclear

223 tes to the lung destruction that accompanies cigarette smoking; it simultaneously inhibits lung tumor

224 We show herein, for the first time, that cigarette smoking leads to an increase in platelet-activ

225 Cigarette smoking leads to upregulation of brain nicotin

226 Cigarette smoking leads to upregulation of nicotinic ace

227 d as critical neural substrates perpetuating cigarette smoking, little is known about their circuit-l

228 diometabolic risk factors, including current cigarette smoking, low fruit and vegetable intake, low p

229 Study 2: to isolate the effects of cigarette smoking, marijuana intoxication, withdrawal, a

230 brain activation, genetic variation, and/or cigarette smoking may account for this mixed response pr

231 Our findings suggest that cigarette smoking may increase Alzheimer's disease onset

232 These findings suggest that active cigarette smoking may increase susceptibility to acute r

233 se pathways that are activated by asthma and cigarette smoking may optimize therapeutic responses.

234 Prenatal exposure to maternal cigarette smoking may promote obesity by enhancing dieta

235 of whom were exposed prenatally to maternal cigarette smoking (mean [SD], 11.1 [6.8] cigarettes/d).

236 Cigarette smoking measured both by history and biomarker

237 eral epidemiological studies have shown that cigarette smoking might alter the incidence of Alzheimer

238 Cigarette smoking more than doubled HSIL risk.

239 One woman had AC. Cigarette smoking more than doubled HSIL risk.

240 Six lifestyle factors, including cigarette smoking, obesity, no regular use of nonsteroid

241 nd meta-analysis was to assess the impact of cigarette smoking on clinical outcomes following periodo

242 ative effect of self-reported tooth loss and cigarette smoking on COPD among United States adults age

243 vides potential insights into the effects of cigarette smoking on gene expression in whole blood and

244 dearth of studies regarding the influence of cigarette smoking on periodontal inflammatory conditions

245 55-65 years, with at least 20 pack-years of cigarette smoking or current smokers.

246 proximate steady-state concentration between cigarette smoking or vaping, or during nicotine patch us

247 [OR] = 6.31; 95% CI, 5.39-7.39) and current cigarette smoking (OR = 5.96; 95% CI, 5.67-6.27).

248 s (OR = 7.42; 95% CI, 5.63-9.79) and current cigarette smoking (OR = 7.88; 95% CI, 6.01-10.32).

249 d understanding of causal mechanisms linking cigarette smoking, oral health, and COPD, particularly t

250 cific associations were observed for current cigarette smoking (P = 0.05 among adenomas and P < 0.001

251 tification of comorbid conditions related to cigarette smoking, particularly cardiovascular diseases,

252 atherosclerosis through pathways other than cigarette smoking per se.

253 lesterol, and glucose) and health behaviors (cigarette smoking, physical activity, diet, and body mas

254 evalence of the five major HRBs-alcohol use; cigarette smoking, physical inactivity, unhealthy diet,

255 Two-sided z tests comparing cigarette smoking prevalence revealed no significant dif

256 roviders should counsel their patients about cigarette smoking, preventive dental care, and COPD risk

257 Cigarette smoking promotes body weight reduction in huma

258 vy drinking, treatment attendance, drug use, cigarette smoking, psychiatric symptoms, and HIV-risk be

259 in the late luteal phase, whereas aging and cigarette smoking reduced (11)C-vorozole uptake.

260 We tested the hypothesis that cigarette smoking-relevant nicotine inhalation during pr

261 Substantial progress has been made, but cigarette smoking remains one of the most pressing globa

262 Cigarette smoking remains the leading avoidable cause of

263 rovide some mechanistic explanations whereby cigarette smoking renders a patient susceptible to tuber

264 s coexpressed with the microRNA signature of cigarette smoking revealed enrichment for immune-related

265 Passive cigarette smoking showed very little, if any, increased

266 Cigarette smoking, specifically current smoking, remains

267 After adjusting for cigarette smoking status, participants with high (>3 mg/

268 Associations were strongest for parental cigarette smoking status; compared to children of non-sm

269 tooth loss (0, 1 to 5, 6 to 31, or all) and cigarettes smoking status (never, former, or current) wi

270 sychosocial, and behavioral risk factors for cigarette smoking, the pooled odds ratio for subsequent

271 and the private sector to reduce the toll of cigarette smoking through reduced initiation and increas

272 uding diabetes mellitus, hyperlipidemia, and cigarette smoking to cases.

273 andenburg, Germany, who had complete data on cigarette smoking, tooth loss, and covariates.

274 S) of complex behavioural phenotypes such as cigarette smoking typically employ self-report phenotype

275 es have high rates of marijuana relapse, and cigarette smoking versus recent abstinence does not dire

276 he second leading cause of lung cancer after cigarette smoking via inhalation; however, exposure thro

277 The report concluded that cigarette smoking was a cause of lung cancer in men and

278 Conclusion Cigarette smoking was associated with a reduction in sur

279 Cigarette smoking was associated with higher prevalence

280 In contrast, cigarette smoking was associated with increased IgM anti

281 Cigarette smoking was associated with lower concentratio

282 The question of whether cigarette smoking was associated with lung cancer was ce

283 t finding from VTE subtype analyses was that cigarette smoking was associated with provoked but not u

284 History of cigarette smoking was available and allowed classificati

285 ignificant gene-environment interaction with cigarette smoking was confirmed.

286 lung cancer risk between hyperkeratosis and cigarette smoking was identified, which suggests that pa

287 udy (2012-2014), a study of 332 adults whose cigarette smoking was measured in a naturalistic environ

288 A Cox model, adjusting for pack-years of cigarette smoking, was used to calculate hazard ratios a

289 okers, both pharmacologic administration and cigarette smoking were associated with activity decrease

290 d 95% confidence intervals for pack-years of cigarette smoking were estimated by logistic regression,

291 Individual-level data on parental cigarette smoking were obtained from 12 case-control stu

292 hypertension, high blood sugar, and regular cigarette smoking were rare.

293 ver time (a measure similar to pack-years of cigarette smoking), were calculated using predicted BMIs

294 non-cigarette smokers had subsequently tried cigarette smoking, were current (past 30 days) cigarette

295 in general that is not driven exclusively by cigarette smoking, which is the main risk factor for chr

296 Although reductions in cigarette smoking will achieve the greatest impact on lu

297 amine the association of current or previous cigarette smoking with clinical and inflammatory variabl

298 y population, we examined the association of cigarette smoking with DNA methylation using single nucl

299 pidemiologic evidence clearly links maternal cigarette smoking with FGR, insight into the molecular m

300 ociations of SNPs, age, body mass index, and cigarette smoking with the rate of progression and relat